Psychiatry Research: Neuroimaging
Volume 172, Issue 2 , Pages 136-139 , 15 May 2009

Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive–compulsive disorder

  • Paul Daniel Arnold

      Affiliations

    • Program in Genetics and Genomic Biology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8
    • Department of Psychiatry, 1st Floor Elm Wing, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8
    • Neurogenetics Section, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, 1st Floor Elm Wing, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8. Tel.: +1 416 813 6936; fax: +1 416 813 5326.
    • ,
  • Frank P. MacMaster

      Affiliations

    • Wayne State University, Detroit, MI, United States
    • The Children's Hospital of Michigan, Detroit, MI, United States
    • ,
  • Margaret A. Richter

      Affiliations

    • Anxiety Disorders Clinic, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • ,
  • Gregory L. Hanna

      Affiliations

    • University of Michigan, Ann Arbor, MI, United States
    • ,
  • Tricia Sicard

      Affiliations

    • Neurogenetics Section, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • ,
  • Eliza Burroughs

      Affiliations

    • Anxiety Disorders Clinic, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • ,
  • Yousha Mirza

      Affiliations

    • Wayne State University, Detroit, MI, United States
    • The Children's Hospital of Michigan, Detroit, MI, United States
    • ,
  • Phillip C. Easter

      Affiliations

    • Wayne State University, Detroit, MI, United States
    • The Children's Hospital of Michigan, Detroit, MI, United States
    • ,
  • Michelle Rose

      Affiliations

    • Wayne State University, Detroit, MI, United States
    • The Children's Hospital of Michigan, Detroit, MI, United States
    • ,
  • James L. Kennedy

      Affiliations

    • Neurogenetics Section, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • ,
  • David R. Rosenberg

      Affiliations

    • Wayne State University, Detroit, MI, United States
    • The Children's Hospital of Michigan, Detroit, MI, United States

Received 9 January 2009 ,Revised 12 February 2009 ,Accepted 19 February 2009.

References 

  1. Arnold, P.D., 2007. Glutamate genes in obsessive–compulsive disorder including childhood onset cases and neuroimaging. Ph.D. Dissertation. University of Toronto, Toronto.
  2. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive–compulsive disorder: a preliminary study. Psychopharmacology (Berl). 2004;174(4):530–538
  3. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive–compulsive disorder. Archives of General Psychiatry. 2006;63(7):769–776
  4. Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F, et al. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biological Psychiatry. 2008;63:1178–1184
  5. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences. 1987;508:333–348
  6. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive–compulsive disorder. Archives of General Psychiatry. 2006;63(7):778–785
  7. Gorroochurn P, Hodge SE, Heiman GA, Greenberg DA. A unified approach for quantifying, testing and correcting population stratification in case-control association studies. Human Heredity. 2007;64(3):149–159
  8. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959;32(1):50–55
  9. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 1967;6(4):278–296
  10. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36(7):980–988
  11. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry. 1989;28:566–573
  12. Macmaster FP, O'Neill J, Rosenberg DR. Brain imaging in pediatric obsessive–compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47 (11), 1267–1272. 2008;
  13. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews. Neuroscience. 2006;7(10):818–827
  14. Miyatake R, Furukawa A, Suwaki H. Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Molecular Psychiatry. 2002;7(10):1101–1106
  15. Page GP, George V, Go RC, Page PZ, Allison DB. “Are we there yet?”: deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. American Journal of Human Genetics. 2003;73:711–719
  16. Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig DW, Pearson JV, et al. Common Kibra alleles are associated with human memory performance. Science. 2006;314(5798):475–478
  17. Pauls DL. The genetics of obsessive compulsive disorder: a review of the evidence. American Journal of Medical Genetics C Seminars in Medical Genetics. 2008;148(2):133–139(May 15)
  18. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  19. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR in Biomedicine. 2001;14(4):260–264
  20. Rosenberg D, Keshavan M. Toward a neurodevelopmental model of obsessive–compulsive disorder. Biological Psychiatry. 1998;43:623–640
  21. Rosenberg D, MacMaster F, Keshavan M, Fitzgerald K, Stewart C, Moore G. Decrease in caudate glutamatergic concentrations in pediatric obsessive–compulsive disorder patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39(9):1096–1103
  22. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43(9):1146–1153
  23. Rosenberg DR, MacMaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, et al. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biological Psychiatry. 2005;58(9):700–704
  24. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children's Yale–Brown Obsessive Compulsive Scale: reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36(6):844–852
  25. Stanley JA, Drost DJ, Williamson PC, Thompson RT. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magnetic Resonance in Medicine. 1995;34(1):17–24
  26. Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, et al. Association of the SLC1A1 glutamate transporter gene and obsessive–compulsive disorder. American Journal of Medical Genetics B Neuropsychiatric Genetics. 2007;144(8):1027–1033
  27. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive–compulsive disorder. American Journal of Psychiatry. 2004;161(6):1049–1056
  28. Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, et al. Anterior cingulate glutamate–glutamine levels predict symptom severity in women with obsessive–compulsive disorder. Australian and New Zealand Journal of Psychiatry. 2008;42(6):467–477

PII: S0925-4927(09)00052-3

doi: 10.1016/j.pscychresns.2009.02.005

Psychiatry Research: Neuroimaging
Volume 172, Issue 2 , Pages 136-139 , 15 May 2009

Article Tools

* Image Usage & Resolution